Em Minas Gerais 25 municípios enfrentam o último surto de febre amarela silvestre desde o início do ano. A Biblioteca Virtual da AMMG selecionou os principais artigos sobre o tema. Confira:
Kantor AM, Dong S, Held NL, Ishimwe E, Passarelli AL, Clem RJ, Franz AW.
Insect Mol Biol. 2017 Feb;26(1):113-126. doi: 10.1111/imb.12275.
PMID: 28054419
A Yellow Fever Epidemic: A New Global Health Emergency?
Lucey D, Gostin LO.
JAMA. 2016 Jun 28;315(24):2661-2. doi: 10.1001/jama.2016.6606. No abstract available.
PMID: 27158803
Características epidemiológicas da febre amarela no Brasil, 2000-2012.
Cavalcante KR, Tauil PL.
Epidemiol Serv Saude. 2016 Jan-Mar;25(1):11-20. doi: 10.5123/S1679-49742016000100002. English, Portuguese.
PMID: 27861674
Yellow Fever Remains a Potential Threat to Public Health.
Vasconcelos PF, Monath TP.
Vector Borne Zoonotic Dis. 2016 Aug;16(8):566-7. doi: 10.1089/vbz.2016.2031.
PMID: 27400066
Tabachnick WJ.
Annu Rev Virol. 2016 Sep 29;3(1):125-145.
PMID: 27482902
Yellow fever vaccination - Once in a lifetime?
Travel Med Infect Dis. 2016 Dec 21. pii: S1477-8939(16)30210-1. doi: 10.1016/j.tmaid.2016.12.003. [Epub ahead of print] No abstract available.
PMID: 28013052
Fractional dosing of yellow fever vaccine to extend supply: a modelling study.
Wu JT, Peak CM, Leung GM, Lipsitch M.
Lancet. 2016 Dec 10;388(10062):2904-2911. doi: 10.1016/S0140-6736(16)31838-4.
PMID: 27837923
Wieten RW, Jonker EF, van Leeuwen EM, Remmerswaal EB, Ten Berge IJ, de Visser AW, van Genderen PJ, Goorhuis A, Visser LG, Grobusch MP, de Bree GJ.
PLoS One. 2016 Mar 15;11(3):e0149871. doi: 10.1371/journal.pone.0149871.
PMID: 26977808
Booster dose after 10 years is recommended following 17DD-YF primary vaccination.
Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, et. al.
Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693.
PMID: 26360663
Fernandez-Garcia MD, Meertens L, Chazal M, Hafirassou ML, Dejarnac O, Zamborlini A, Despres P, Sauvonnet N, Arenzana-Seisdedos F, Jouvenet N, Amara A.
MBio. 2016 Feb 9;7(1):e01956-15. doi: 10.1128/mBio.01956-15.
PMID: 26861019
A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination.
Jean K, Donnelly CA, Ferguson NM, Garske T.
Am J Trop Med Hyg. 2016 Dec 7;95(6):1435-1439.
PMID: 27928091
Watson AM, Lam LK, Klimstra WB, Ryman KD.
PLoS Pathog. 2016 Jul 27;12(7):e1005786. doi: 10.1371/journal.ppat.1005786.
PMID: 27463517
Questions regarding the safety and duration of immunity following live yellow fever vaccination.
Amanna IJ, Slifka MK.
Expert Rev Vaccines. 2016 Dec;15(12):1519-1533.
PMID: 27267203
Yellow fever vaccine-associated viscerotropic disease: current perspectives.
Thomas RE.
Drug Des Devel Ther. 2016 Oct 12;10:3345-3353. Review.
PMID: 27784992
Adverse event reports following yellow fever vaccination, 2007-13.
Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE.
J Travel Med. 2016 Jul 4;23(5). pii: taw045. doi: 10.1093/jtm/taw045.
PMID: 27378369
Wieten RW, Jonker EF, Pieren DK, Hodiamont CJ, van Thiel PP, van Gorp EC, de Visser AW, Grobusch MP, Visser LG, Goorhuis A.
Vaccine. 2016 Mar 4;34(10):1247-51. doi: 10.1016/j.vaccine.2016.01.037.
PMID: 26845742
Monath TP, Vasconcelos PF.
J Clin Virol. 2015 Mar;64:160-73. doi: 10.1016/j.jcv.2014.08.030. Review.
PMID: 25453327